Recent Posts
- FORUS Therapeutics Inc. annonce que Santé Canada a approuvé BESREMI® (ropeginterféron alfa-2b) pour le traitement de la polycythémie vraie (PV)
- FORUS Therapeutics Joins PharmaEssentia to Strengthen Focus on Hematology and Oncology in Canada
- WELCOME BACK, Marie-Josèphe Champagne
- XPOVIO® est maintenant financé au Québec
- WELCOME, Lisa Kolomaya
Archives
- July 2026
- June 2026
- November 2025
- October 2025
- March 2025
- November 2024
- September 2024
- April 2024
- November 2023
- October 2023
- September 2023
- June 2023
- May 2023
- April 2023
- January 2023
- October 2022
- September 2022
- July 2022
- June 2022
- May 2022
- April 2022
- February 2022
- December 2021
- September 2021
- July 2021
- June 2021
- January 2021
Recent Comments